CrossrefInfokarte
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
Blood and Lymphatic Cancer: Targets and Therapy · 2017
DOI: 10.2147/blctt.s130197 ↗Abstract
Kein Abstract verfügbar.
EUVIMED